March 12, 2026
4 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Pyoderma gangrenosum is a difficult-to-treat wound disease that may soon have promising new therapies.In this Beneath the Surface video interview, Joel M. Gelfand, MD, MSCE, FAAD, the James J. Leyden Professor of Clinical Investigation and professor of dermatology and epidemiology at University of Pennsylvania’s Perelman School of Medicine and Healio Dermatology’s Chief Medical
March 12, 2026
4 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Chronic wounds are an immense burden for patients. If left untreated, chronic wounds can be life-threatening, making effective…

Joel M. Gelfand, MD, MSCE, FAAD, is Chief Medical Editor of Healio Dermatology and the James J. Leyden Professor of Dermatology…

For decades, biologics have been the gold standard for psoriasis treatment. Now, the psoriasis therapeutic landscape is…

Find the latest Wound Management news articles, videos, podcasts, and meeting coverage from medical experts and key opinion…

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss…